Conference Coverage: ESMO 2023 – Focus on Lung Cancer
Expert perspectives and strategic insights on the latest therapeutic developments and translational research in lung cancer treatment
October 23, 2023
Faculty Chair
Corey J. Langer, MD, FACP
University of Pennsylvania, Philadelphia, USA
FACULTY MEMBERS
Federico Cappuzzo, MD, PhD
AUSL della Romagna-Ravenna, Italy
Egbert Smit, MD, PhD
The Netherlands Cancer Institute, Amsterdam, the Netherlands
Christian Rolfo, MD, PhD
Icahn School of Medicine at Mount Sinai, New York, NY, USA
Sandip Patel, MD
UC San Diego Health, CA, USA
Marina Chiara Garassino, MD
University of Chicago, IL, USA
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Immunotherapy in Resectable NSCLC
- Immunotherapy in Stage III/IV NSCLC
- Second-Line Therapy and Beyond
- Oncogene-Driven NSCLC: EGFR
- Oncogene-Driven NSCLC: Other Mutations
- Oncogene-Driven NSCLC: Fusions
- SCLC and New Agents/Targets
- Open Discussion: Major Breakthroughs Over the Coming Years in Lung Cancer
